Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kündgen, L
162  Ergebnisse:
Personensuche X
?
1

The new WHO 2022 and ICC proposals for the classification o..:

Nachtkamp, K. ; Strupp, C. ; Vukelja, M....
Leukemia.  38 (2024)  2 - p. 442-445 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome a..:

Pfeilstöcker, M. ; Tuechler, H. ; Ades, L....
Leukemia Research.  128 (2023)  - p. 107230 , 2023
Link: https://doi.org/10.1016/..
 
?
3

P772: PROGNOSTIC IMPACT OF DISEASE-RELATED RISK FACTORS AND..:

Lesch, C. ; Kündgen, A. ; Nachtkamp, K....
HemaSphere.  6 (2022)  - p. 667-668 , 2022
Link: https://doi.org/10.1097/..
 
?
4

P589: AGE AND AGE-ADAPTED RISK FACTORS HIGHLY INFLUENCE SUR..:

Nachtkamp, K. ; Zahner, C. ; Fricke, A....
HemaSphere.  6 (2022)  - p. 488-489 , 2022
Link: https://doi.org/10.1097/..
 
?
5

P532: ACUTE MYELOID LEUKEMIA (AML): UNICENTRIC REPORT ON 10..:

Fricke, A. ; Nachtkamp, K. ; Döhner, K....
HemaSphere.  6 (2022)  - p. 431-432 , 2022
Link: https://doi.org/10.1097/..
 
?
6

Analysis of the impact of adherence to guidelines and exper..:

Kasprzak, A. ; Nachtkamp, K. ; Kondakci, M....
Annals of Hematology.  100 (2020)  2 - p. 455-463 , 2020
Link: https://doi.org/10.1007/..
 
?
7

The IPSS-R has prognostic impact in untreated patients with..:

Kaivers, J. ; Lauseker, M. ; Hildebrandt, B....
Leukemia Research.  72 (2018)  - p. 27-33 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Incidence and prognostic impact of ASXL2 mutations in adult..:

Jahn, N ; Agrawal, M ; Bullinger, L...
Leukemia.  31 (2017)  4 - p. 1012-1015 , 2017
Link: https://doi.org/10.1038/..
 
?
9

Epidemiological, genetic, and clinical characterization by ..:

German-Austrian AML Study Group (AMLSG) ; Nagel, Gabriele ; Weber, D....
Annals of Hematology.  96 (2017)  12 - p. 1993-2003 , 2017
Link: https://doi.org/10.1007/..
 
?
10

Transfusion Need and Comorbidities are Independent Prognost..:

Neukirchen, J. ; Strupp, C. ; Schuler, E....
Leukemia Research.  55 (2017)  - p. S148 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Reduced-toxicity conditioning for allogeneic hematopoietic ..:

Wais, V ; Kündgen, L ; Bohl, S R...
Bone Marrow Transplantation.  53 (2017)  1 - p. 94-96 , 2017
Link: https://doi.org/10.1038/..
 
?
12

DNMT3A mutant transcript levels persist in remission and do..:

for the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG) ; Gaidzik, V I ; Weber, D...
Leukemia.  32 (2017)  1 - p. 30-37 , 2017
Link: https://doi.org/10.1038/..
 
?
13

Condensed versus standard schedule of high-dose cytarabine ..:

Jaramillo, S ; Benner, A ; Krauter, J...
Blood Cancer Journal.  7 (2017)  5 - p. e564-e564 , 2017
Link: https://doi.org/10.1038/..
 
?
14

Patients with IPSS-R Intermediate Risk can be Separated Int..:

Nachtkamp, K. ; Reykowski, T. ; Hildebrandt, B....
Leukemia Research.  55 (2017)  - p. S147 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Impact of salvage regimens on response and overall survival..:

Wattad, M ; Weber, D ; Döhner, K...
Leukemia.  31 (2017)  6 - p. 1306-1313 , 2017
Link: https://doi.org/10.1038/..
 
1-15